Dachaigh › Ailse metastatach › Wisconsin › Madison
Sgrùdaidhean clionaigeach Ailse metastatach ann an Madison, WI
Tha 21 sgrùdaidhean airson Ailse metastatach a’ lorg phàirtichean aig làraichean ann agus timcheall air Madison (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center, Madison
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- University of Wisconsin Carbone Cancer Center, Madison
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
A’ fastadhÌre 1
- University of Wisconsin - Carbone Cancer Center, Madison
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
A’ fastadhÌre 1
- Wisconsin Institute for Medical Research, Madison
A Study of ASP3082 in Adults With Advanced Solid Tumors
A’ fastadhÌre 1
- University of Wisconsin Hospital, Madison
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A’ fastadhÌre 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
A’ fastadhÌre 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Biomarkers to Detect Endocrine Therapy Resistance
A’ fastadhÌre 2
- UW Carbone Cancer Center, Madison
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
A’ fastadhÌre 1
- UW Carbone Cancer Center, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
A’ fastadhÌre 1
- University of Wisconsin, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
A’ fastadhÌre 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
A’ fastadhÌre 2/3
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- UW Carbone Cancer Center, Madison
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
A’ fastadhÌre 1
- University of Wisconsin Carbone Cancer Center, Madison
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
A’ fastadhÌre 1
- SSM Health Cancer Care, Madison
In Vivo Liquid Biopsy of Melanoma (Cytophone)
A’ fastadhFàilte do shaor-thoilich fhallain
- SSM Health Dean Medical Group Specialty Services, Madison
Sgrùdaidhean Ailse metastatach ann am bailtean eile
- Houston, TX104 sgrùdaidhean
- New York City, NY93 sgrùdaidhean
- Nashville, TN70 sgrùdaidhean
- Boston, MA63 sgrùdaidhean
- Los Angeles, CA57 sgrùdaidhean
- St. Louis, MO54 sgrùdaidhean
- Arlington, VA53 sgrùdaidhean
- Philadelphia, PA46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Antonio, TX44 sgrùdaidhean
- Washington, DC43 sgrùdaidhean
- Dallas, TX42 sgrùdaidhean
Sgrùdaidhean eile ann an Madison
- Aillse Prostata29 sgrùdaidhean
- Aillse colorectal23 sgrùdaidhean
- Aillse a' bhroilleach22 sgrùdaidhean
- Leukemia myeloid geur16 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag16 sgrùdaidhean
- Melanoma15 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Cancer Ovarian13 sgrùdaidhean
- Aillse a' Bhroinn11 sgrùdadh
- Cancer Pancreatic10 sgrùdaidhean
- Ailseachadh nan Sgamhan10 sgrùdaidhean
- Myeloma iomaill9 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.